AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Maine

LD1034

An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults

Status

Did not pass; died when the session ended

2025 Session

IntroducedMar 12, 2025 (done)
PassedJun 3, 2025 (done)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Grayson Lookner (Democrat)
Type: Decriminalization
Substances: Psilocybin

Official text

Summary (from PoliPsy)

An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: legislature.maine.gov

Legislative history

June 10, 2025
Failed
June 10, 2025
Failed
June 3, 2025
Enrolled (Passed Both Chambers)
June 2, 2025
Engrossed (Passed One Chamber)
March 12, 2025
Referred
March 12, 2025
Introduced

Loading bill…